الابحاث

South Egypt Cancer Institute

Assiut University

Department of Clinical Pathology
# Title Research Member Research Year
51 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Asmaa Mohamed Zahran Omar 2021
52 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Dr. Iman Hassan Ahmed Hamada 2021
53 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
54 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Eman Hosny Mohammed Ibrahim 2021
55 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Duaa Abdel-Samia Mohamed Ali 2021
56 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Asmaa Mohamed Zahran Omar 2021
57 Micro-RNA 155 in non-Hodgkin lymphoma ميرنا وجيه وديع ناروز 2021
58 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
59 Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues Prof. Douaa Mohamed Sayed Hussein 2021
60 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Dr. Iman Hassan Ahmed Hamada 2021